Industry News
Agenix opens new avenues with diagnostics deal
Agenix (ASX:AGX) has arranged to license a diagnostic device platform from Tyrian Diagnostics in a share swap deal. [ + ]
R&D Tax Incentive remains untouched as tax reform stalls
The government’s Business Tax Working Group has failed to reach agreement on how to fund a cut in corporate tax, leaving the R&D Tax Incentive as is. [ + ]
Destructive pea weevils on the way out
Farmers around the world are a step closer to eliminating the chemical spraying of field peas for the destructive pea weevil, thanks to research by agricultural scientists from The University of Western Australia (UWA). [ + ]
Opportunity to work with world-class scientists at summer school
Southern Cross University’s 2013 Science Summer School gives undergraduates or recent graduates the opportunity to team up with one of the university’s leading researchers to undertake a short science-based project over four weeks. [ + ]
Avexa's antibiotic storms lab tests
Avexa's (ASX:AVX) anti-bacterial compound AVX13616 has performed well in lab tests conducted by licensee Valevia Pharmaceuticals. [ + ]
Australian biotechs significantly outperforming ASX and Nasdaq
The Australian life science index is known for its volatility, but over the past decade it has outperformed the All Ordinaries and the Nasdaq by considerable margins. [ + ]
Are schizophrenia and autism close relations?
New research by Dr Mark Weiser of Tel Aviv University’s Sackler Faculty of Medicine and the Sheba Medical Center has revealed that ASD appears to share a root cause with other mental illnesses, including schizophrenia and bipolar disorder. [ + ]
Biota cleared to merge with Nabi
Biota Holdings (ASX:BTA) has been cleared to merge with Nabi Biopharmaceuticals after shareholders in both companies approved the deal. [ + ]
Generations: how cells inherit information
A new study has helped solve the problem of how epigenetic information is passed from one generation of cells to the next. [ + ]
Latest journal features AusBiotech 2012, tech transfer and more…
AusBiotech is pleased to announce that the bumper special edition of AusBiotech’s journal, Australasian Biotechnology, is now published, featuring a sneak peek at next week’s industry conference of the year, AusBiotech 2012, as well as a feature on tech transfer and biotechnology in Asia. [ + ]
Test strip earnings boost UBI revenue
Universal Biosensors (ASX:UBI) boosted its Q3 revenue by 50% and slashed its cash outflow, thanks to contributions from its two coagulation test strip partnerships. [ + ]
Cracking the epigenetic code
A team of researchers at The Australian National University is one step closer to better understanding how organisms function after discovering how epigenetic information is transmitted from one generation of cells to the next. [ + ]
Government steadfast on research funding
The Australian Academy of Science has commended the government’s commitment to maintain funding for science research through the Australian Research Council (ARC) and Cooperative Research Centres (CRCs). [ + ]
Bioniche launches canine cancer product in NA
Bioniche Life Sciences (ASX:BNC) has launched its first canine cancer product, Immunocidin, in the US and Canadian markets. [ + ]
Bluechiip enters sample tracking tie-up
Bluechiip (ASX:BCT) has partnered with Swiss laboratory systems developer Inpeco, agreeing to explore jointly developing Inpeco products with integrated Bluechiip tracking chips. [ + ]

